Kentaro Hirade is an author at Aichi Cancer Center specializing in cell biology, medicine, and cancer research.
Top concepts
MedicineCell BiologyGliomaPathologyPharmacologyTumor BiologyCancer BiologyCell SignalingNeuro-oncologyCancer Research
Publications per year
2022–2023
2
2
High-risk neuroblastoma with NF1 loss of function is targetable using SHP2 inhibition
Jinyang Cai, Sheeba Jacob, Richard Kurupi et al. · Cell Reports · 2022 · 17 citations · Full text
Rows per page
1–2 of 2